Science is unravelling at unprecedented speed. The challenge facing us here at UHSM is to continue to deliver bold re- search and education, for without it we condemn tomorrow’s patients to yester- day’s treatments.
We currently boast over 300 research projects in progress, supported by £6.2m in external funding from Research Coun- cils, charities, UK Government, interna- tional funders and industry, including commercial contracts to develop new medicines, devices and procedures.
From the lab bench to the patient bedside, we support excellent research in cancer, lung, vascular and gastro-intestinal dis- eases, tissue and wound management and medical education. Our pioneering work in organ transplantation and cardiac surgery has earned us a reputation as a centre of excellence.
The Christie is one of Europe’s leading cancer centres, treating more than 40,000 patients a year.
As the largest cancer centre in Europe, we provide radiotherapy through one of the largest radiotherapy departments in the world; chemotherapy on site and through14 other hospitals; highly special- ist surgery for complex and rare cancer; and a wide range of support and diagnos- tic services.
Because of the specialist services we provide around 26% of our patients are referred to us from across the UK. Our private patients unit also provides care for people from across the world.
We are also an international leader in re- search, with world first breakthroughs for over 100 years.
Manchester Mental Health and Social Care Trust
We provide health and social care serv- ices for people with mental health needs across Manchester and were rated as ‘good’ for the quality of our services by the Care Quality Commission in October. Led by CEO Jackie Daniel and a strong Execu- tive team, we are looking to achieve Foun- dation Trust status in October 2010 and have embarked on an ambitious Transfor- mational Work Programme to ensure our service users and carers get the right care, in the right place, at the right time, every time.
We have a strong Research & Develop- ment portfolio and as part of Manchester’s Academic Health Science Centre (MAH- SC) we are committed to realising quality, safety and effectiveness through partner- ship working.
As a proud founding partner in the Man- chester Academic Health Science Centre (MAHSC), and our strong links with the University of Manchester we ensure that our reputation can only be strengthened as we collaborate with others to push the boundaries of medical discovery.
Cancer research in Manchester has been officially ranked the best in the UK.
We are currently implementing an ambi- tious five-year strategy which breaks new ground and is set to transform treatment and care for cancer patients.
Nadine Schofield, Head of Service Transformation:
In January 2010 we will officially launch our Education Academy – a radically new concept for delivering multi-disciplinary education which, we believe, will become a model for other UK healthcare institu- tions to replicate.
An extensive capital investment plan over the next two years includes a new £35 mil- lion patient treatment centre, which will include the largest early clinical trials unit in the world – and a unique network of £17 million Christie radiotherapy centres in other parts of the area to deliver treatment closer to people’s homes.
Our future is mapped out in our Towards 2015 strategy, which sets out our ambi- tions for the next period in our develop- ment as a centre of health excellence – delivering quality safety and care through pioneering research and education.
Angela Ball Research & Development Manager
For more information contact Sarah Walter PA to Mr Brendan Ryan Executive Medical Director, UHSM 0161-291-5422 firstname.lastname@example.org
Government Interrelations is the only specialist organisation whose main focus of support for its members is access to digital communication tools and strategic planning and networking for the government’s QIPP agenda.
Lord Darzi has made the NHS legally bound to innovate.
We work with our members to ensure they fulfil their legal duty by arming them with the tools necessary to share and learn innovative practices as well as assisting them to promote and adopt an innovative culture Trust wide to fulfil their statutory obligations.